Guocai Zhong

4.1k citations

30 papers · 2.8k indexed · 1 hit paper · h-index 17

Co-authors: Michael Farzan Haimin Wang Wenhui He Wenhui Li Zhiyi Jing Yonghe Qi Charles C. Bailey Xiaozhong Peng
Topics: SARS-CoV-2 and COVID-19 Research (8 papers)COVID-19 Clinical Research Studies (6 papers)Hepatitis B Virus Studies (6 papers)
Cited by: Hepatology Epidemiology Infectious Diseases
Journals: Nature Biotechnology Biochemistry Journal of Virology
Partner nations: China United States India

In The Last Decade

Guocai Zhong

28 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

2012 1.6k citations Huan Yan, Guocai Zhong et al. profile →

Peers

Countries citing papers authored by Guocai Zhong

Since Specialization

Citations

This map shows the geographic impact of Guocai Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guocai Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guocai Zhong more than expected).

Fields of papers citing papers by Guocai Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guocai Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guocai Zhong. The network helps show where Guocai Zhong may publish in the future.

Co-authorship network of co-authors of Guocai Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Guocai Zhong. A scholar is included among the top collaborators of Guocai Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guocai Zhong. Guocai Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A peptide conjugate enables systemic injection of the morpholino inducer and more durable induction of T3H38 ribozyme-controlled AAV transgene in mice 2025 ·Gene Therapy ·(unknown),(unknown),Yandong Yin,Guocai Zhong	0
2	Development of a Novel Lysosomal Gene-based Prognostic Panel and Uncovering EIF4EBP1 as a Biomarker for Breast Cancer 2025 ·Current Genomics ·(unknown),(unknown),(unknown),Guocai Zhong,Shujun Zhang	0
3	ASPH dysregulates cell death and induces chemoresistance in hepatocellular carcinoma 2024 ·Cancer Letters ·Jingtao Li,Guocai Zhong,Fengli Hu,Yingnan Zhang,Xiaohang Ren,(unknown),(unknown),(unknown),Junwei Li,(unknown),Yao Zhang,Ting Wang,Qiushi Lin,Xiaoqun Dong,(unknown)	4
4	Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant 2023 ·mBio ·Wenlin Ren,Yu Zhang,(unknown),Ziyi Wang,Jun Lan,Kunpeng Liu,Xuekai Zhang,Xue Hu,Chen Yang,Guocai Zhong,Rong Zhang,Xinquan Wang,Chao Shan,Qiang Ding	11
5	Evolution of SARS-CoV-2 Spikes shapes their binding affinities to animal ACE2 orthologs 2023 ·Microbiology Spectrum ·(unknown),Yujun Li,(unknown),Xu-Dong Hou,Haimin Wang,(unknown),(unknown),He Zhang,(unknown),Hong Pan,Chao Li,Hua Lin,(unknown),Qiang Ding,Yingjie Wang,Jiali Gao,Guocai Zhong	4
6	Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection 2023 ·Microbiology Spectrum ·(unknown),(unknown),Yujun Li,(unknown),Zhaoyong Zhang,Haimin Wang,(unknown),Yanqun Wang,Chao Li,(unknown),Hua Lin,Yandong Yin,Jincun Zhao,Guocai Zhong	5
7	Characterization of SARS-CoV-2 Variants B.1.617.1 (Kappa), B.1.617.2 (Delta), and B.1.618 by Cell Entry and Immune Evasion 2022 ·mBio ·Wenlin Ren,Xiaohui Ju,Mingli Gong,Jun Lan,Yanying Yu,Quanxin Long,Devin Kenney,Aoife K. O’Connell,Yu Zhang,Jin Zhong,Guocai Zhong,Florian Douam,Xinquan Wang,Ailong Huang,Rong Zhang,Qiang Ding	23
8	Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire 2021 ·Molecular Therapy ·Tianling Ou,Wenhui He,Brian D. Quinlan,Yan Guo,Mai H. Tran,Pabalu P. Karunadharma,HaJeung Park,Meredith E. Davis-Gardner,Yiming Yin,Xia Zhang,Haimin Wang,Guocai Zhong,Michael Farzan	10
9	Mutation Y453F in the spike protein of SARS-CoV-2 enhances interaction with the mink ACE2 receptor for host adaption 2021 ·PLoS Pathogens ·Wenlin Ren,Jun Lan,Xiaohui Ju,Mingli Gong,Quanxin Long,(unknown),Yanying Yu,Jianping Wu,Jin Zhong,Rong Zhang,Shilong Fan,Guocai Zhong,Ailong Huang,Xinquan Wang,Qiang Ding	48
10	A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020 2021 ·Molecular Therapy — Nucleic Acids ·Mai H. Tran,HaJeung Park,Christopher L. Nobles,Pabalu P. Karunadharma,Li Pan,Guocai Zhong,Haimin Wang,Wenhui He,Tianling Ou,Gogce Crynen,(unknown),(unknown),Huihui Mou,Michael Farzan	29
11	An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines 2021 ·mBio ·Yan Guo,Wenhui He,Huihui Mou,Lizhou Zhang,(unknown),Shoujiao Peng,Amrita Ojha,(unknown),Mark S. Parcells,Guangxiang Luo,Wenhui Li,Guocai Zhong,Hyeryun Choe,Michael Farzan,Brian D. Quinlan	19
12	A reversible RNA on-switch that controls gene expression of AAV-delivered therapeutics in vivo 2019 ·Nature Biotechnology ·Guocai Zhong,Haimin Wang,Wenhui He,Yujun Li,Huihui Mou,(unknown),Mai H. Tran,Tianling Ou,Yiming Yin,Huitian Diao,Michael Farzan	75
13	Conditional Regulation of Gene Expression by Ligand-Induced Occlusion of a MicroRNA Target Sequence 2018 ·Molecular Therapy ·Huihui Mou,Guocai Zhong,Matthew R. Gardner,Haimin Wang,Yiwen Wang,(unknown),Michael Farzan	23
14	An Investigation and Comparison of the Blending of LDPE and PP with Different Intrinsic Viscosities of PET 2018 ·Polymers ·Shichang Chen,Li-Hao Zhang,Zhang Guo,Guocai Zhong,Jian Li,Xianming Zhang,Wenxing Chen	25
15	Cpf1 proteins excise CRISPR RNAs from mRNA transcripts in mammalian cells 2017 ·Nature Chemical Biology ·Guocai Zhong,Haimin Wang,Yujun Li,Mai H. Tran,Michael Farzan	51
16	Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide 2013 ·Journal of Virology ·Huan Yan,Xiaozhong Peng,Wenhui He,Guocai Zhong,Yonghe Qi,B Ren,Zhenchao Gao,Zhiyi Jing,Mei Song,Guangwei Xu,Jianhua Sui,Wenhui Li	153
17	Nonmuscle Myosin Heavy Chain IIA Is a Critical Factor Contributing to the Efficiency of Early Infection of Severe Fever with Thrombocytopenia Syndrome Virus 2013 ·Journal of Virology ·Yinyan Sun,Yonghe Qi,(unknown),Wenqing Gao,Pan Chen,Liran Fu,Xiaozhong Peng,Haimin Wang,Zhiyi Jing,Guocai Zhong,Wenhui Li	93
18	Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence 2011 ·Applied Microbiology and Biotechnology ·Jiaye Wang,Wenting Song,(unknown),Wenjiang Chen,Dan Yang,Guocai Zhong,(unknown),(unknown),(unknown),Hong Ling	42
19	A sensitive HIV-1 envelope induced fusion assay identifies fusion enhancement of thrombin 2010 ·Biochemical and Biophysical Research Communications ·(unknown),Guocai Zhong,(unknown),(unknown),Yan Li,(unknown),Toshio Hattori,Hong Ling,Feng‐Min Zhang	5
20	[The hepatitis A virus isolated and adapted in human diploid fibroblast cells (KMB17)]. 1996 ·PubMed ·(unknown),Guocai Zhong,Xin Yang,(unknown)	2

About Guocai Zhong

Guocai Zhong is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 30 papers that have together received 2.8k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), COVID-19 Clinical Research Studies (6 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Hepatology (1.2k citations), Epidemiology (1.7k citations) and Infectious Diseases (702 citations). Guocai Zhong has collaborated with scholars based in China, United States and India. Frequent co-authors include Michael Farzan, Haimin Wang, Wenhui He, Wenhui Li, Zhiyi Jing, Yonghe Qi, Charles C. Bailey, Xiaozhong Peng, Jianhua Sui and Zhenchao Gao. Their work appears in journals such as Nature Biotechnology, Biochemistry and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact